drugset / Trial / NCT00060996
Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess and compare the safety of continuous and daily subcutaneous Remodulin therapy in patients with critical limb ischemia (CLI) with no planned vascular interventional procedures; and to determine the effect of Remodulin on wound healing and treadmill walk distance.
Timeline
- Start
- 2003-02
- Primary completion
- 2004-09
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | — | Subcutaneous |